Bone Biologics (BBLG) Interest Expenses (2016 - 2017)

Historic Interest Expenses for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $1.5 million.

  • Bone Biologics' Interest Expenses changed N/A to $1.5 million in Q4 2017 from the same period last year, while for Dec 2017 it was $4.4 million, marking a year-over-year increase of 32855.44%. This contributed to the annual value of $805109.0 for FY2021, which is 1933.39% down from last year.
  • As of Q4 2017, Bone Biologics' Interest Expenses stood at $1.5 million.
  • Bone Biologics' 5-year Interest Expenses high stood at $1.5 million for Q4 2017, and its period low was $310089.0 during Q1 2016.